1.16
price up icon0.00%   0.00
after-market Dopo l'orario di chiusura: 1.18 0.02 +1.72%
loading

Allogene Therapeutics Inc Azioni (ALLO) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Revenues
-
- - - 0.022
Operating Expenses
7.77%
65.19
60.49 71.77 71.43 69.53
Operating Income/Loss
7.77%
-65.19
-60.49 -71.77 -71.43 -69.50
Nonoperating Income/Loss
449.09%
5.458
0.994 5.481 5.073 4.504
Income/Loss From Equity Method Investments
-
- -1.134 0.375 -0.929
Income/Loss From Continuing Operations Before Tax
0.40%
-59.73
-59.50 -66.29 -66.36 -65.00
Income/Loss From Continuing Operations After Tax
0.34%
-59.73
-59.94 -66.29 -66.36 -65.00
Net Income/Loss
0.34%
-59.73
-59.94 -66.29 -66.36 -65.00
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
3,970%
215.36
5.2919 209.19 190.03 169.13
Diluted Average Shares
3,970%
215.36
5.2919 209.19 190.03 169.13
Basic Earnings Per Share
0.00%
-0.28
-0.28 -0.32 -0.35 -0.38
Diluted Earnings Per Share
0.00%
-0.28
-0.28 -0.32 -0.35 -0.38
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$24.78
price up icon 0.98%
$84.84
price up icon 1.00%
$24.80
price down icon 8.06%
$103.01
price down icon 1.70%
$134.53
price up icon 1.79%
biotechnology ONC
$300.14
price down icon 2.84%
Capitalizzazione:     |  Volume (24 ore):